NBIX CIK: 914475

Neurocrine Biosciences, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.12
FY22:
1.47
FY23:
1.85
FY24:
2.32
FY25:
2.81
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.25
FY23:
0.25
FY24:
0.57
FY25:
0.62
(positive)
billions USD
FY21:
–
FY22:
0.26
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.21
FY23:
0.33
FY24:
0.49
FY25:
0.71
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.15
FY23:
0.25
FY24:
0.34
FY25:
0.48

All amounts in billions USD Data sources:SEC EDGARTwelve Data